EE116 Implications of Utilizing Survey Versus Administrative Claims Data to Evaluate the Cost of Diabetes Among Medicare Beneficiaries with Cancer: A Methods Study

Autor: McDaniel, C, Lai, TC, McDonald, CP, Rockwell, D, Loh, FE, Chou, C

Publikováno v: In Value in Health July 2022 25(7) Supplement:S357-S357

PDB51 - Systematic Review of the Cost Effectiveness of Dapagliflozin Used to Treat Patients with Type 2 Diabetes Mellitus

Autor: Tsan, J, Duong, T, Girgis, N, Labib, M, Moustakas, A, Loh, FE

Publikováno v: In Value in Health May 2018 21 Supplement 1:S75-S75

Readmissions after unauthorized discharges in the cardiovascular setting.

Autor: Onukwugha E, Mullins CD, Loh FE, Saunders E, Shaya FT, Weir MR

Publikováno v: Medical Care; 2011 Feb, Vol. 49 Issue 2, p215-224, 10p

PCV66 COSTS ASSOCIATED WITH DISCHARGES AGAINST MEDICAL ADVICE IN A CVD POPULATION

Autor: Onukwugha, E, Loh, FE, Weir, MR, Shaya, FT, Mullins, CD

Publikováno v: In Value in Health 2010 13(3):A161-A162

Medicare Part D low-income subsidies expanded in January 2024, but more needs to be done to ensure that eligible beneficiaries enroll.

Autor: Loh FE; Department of Social, Behavioral and Administrative Sciences, Touro College of Pharmacy, New York, NY., Stuart BC; Department of Practice, Sciences, and Health Outcomes Research, University of Maryland School of Pharmacy, Baltimore., Hunt RJ; Department of Policy and Research, Pharmaceutical Research and Manufacturers of America, Washington DC., Negari M; Department of Policy and Research, Pharmaceutical Research and Manufacturers of America, Washington DC.

Publikováno v: Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2024 Mar 01; Vol. 30 (3), pp. 279-289. Date of Electronic Publication: 2024 Feb 07.